Developer docs
API playgroundTry for free, no card

Search company profiles

Precision Cell Systems

Full company profile

uuid00037qu

Namestring
Precision Cell Systems
Legal namestring
Precision Cell Systems, Inc.
Company typeenum
Private
Founded yearint
2025
Descriptiontext

Precision Cell Systems (PCS), headquartered in Livermore, California, is a privately held life-sciences instrumentation company formed in September 2025 through the simultaneous acquisition of S2 Genomics (developer of the Singulator automated tissue dissociation platform) and ORFLO (developer of the Moxi Coulter principle-based cell analyzers), followed in October 2025 by the acquisition of BennuBio (developer of the Velocyt intact spheroid/organoid flow cytometer). The company addresses sample-preparation and analysis bottlenecks for single-cell genomics, cell therapy manufacturing QC, and 3D cell culture workflows, serving an installed base of more than 700 academic, biopharma, core-lab, and clinical-lab customers.

The product portfolio centers on three hardware platforms: the Singulator family (Singulator 100/200/200+) which fully automates fresh, frozen, and FFPE tissue dissociation down to inputs as small as 2 mg or 50 µm curls using a patented minimal-loss cartridge system; the Moxi family (Z, V, GO II, Flow) which uses the Coulter impedance principle to deliver NIST-traceable cell sizing and concentration with <2% CV precision, optionally combined with 1- or 2-channel fluorescence for viability, phenotyping, and reporter assays; and the Velocyt platform (in development) for high-throughput intact spheroid and organoid analysis. Recurring revenue is generated through proprietary consumables—cartridges, cassettes, isolation bundles, and reagents—while instrument revenue is captured via multi-year, quote-based enterprise sales supported by a 3-step workflow assessment process that includes 21 CFR Part 11 compliance capture.

PCS employs a sales-led, enterprise field-sales motion complemented by a direct e-commerce storefront, a large content/resource library (171 Moxi resources, 109 Singulator resources), and a webinar series. Customers include Harvard Medical School, UCSF, Yale, UPenn School of Medicine, Janssen, and consortia such as Tabula Muris, with product performance validated by 156+ peer-reviewed publications across Nature, PNAS, Cell Stem Cell, and Science Immunology. Outputs are validated for downstream compatibility with 10x Genomics (Chromium, Xenium, Visium, MERFISH), Parse Evercode, Mission Bio Tapestri, BioSkryb ResolveDNA, and BioSpyder TempO-LINC, embedding PCS upstream in the dominant single-cell genomics workflow. Leadership comprises CEO Anup Parikh, PhD (ex-BroadOak Capital Partners, 10x Genomics, Mission Bio, Ion Torrent); COO Bruce Leisz (ex-S2 Genomics, Pacific Biosciences, Affymetrix); and CCO Terry Salyer, with operational scaling supported by a partnership with MedTech CDMO Planet Innovation.

Short descriptiontext

Precision Cell Systems is a cell-analysis instrumentation company formed in 2025 from the merger of S2 Genomics and ORFLO and the acquisition of BennuBio, selling automated tissue dissociation (Singulator), Coulter principle cell counters (Moxi), and forthcoming 3D spheroid/organoid flow cytometry (Velocyt) to academic, biopharma, and clinical-lab customers.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLivermore, United States
HQ citystring
Livermore
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
automated tissue dissociation, cell analysis instruments, single-cell genomics, flow cytometry platforms, nuclei isolation systems
Industry4 codes
PRIMARYHLAGAIAE
Microscopy, Imaging & Flow Cytometry Instruments
SECONDARYHLAAABAK
Cell Therapy Quality, Analytics & Release Testing (potency, sterility, comparability)
Healthcare & Life Sciences/Biotechnology & Biologics/Cell Therapy (autologous/allogeneic)
SECONDARYHLAAAIAJ
In Vitro Model Systems & Organoid Platforms (iPSC/organoids, microphysiological systems)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
SECONDARYHLAAABAH
Cell Processing & Ancillary Materials (media, cytokines, beads, vectors, disposables)
Healthcare & Life Sciences/Biotechnology & Biologics/Cell Therapy (autologous/allogeneic)
NAICS code2 codes
  • Analytical Laboratory Instrument Manufacturing334516
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing33451
SIC code1 code
  • Laboratory Analytical Instruments3826
Product category
Cell Analysis Instruments
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Instrument Hardware Sales
TypeHardware Sales
Description

Sale of automated cell analysis instruments including Singulator 200, Singulator 200+, Moxi Z, Moxi V, Moxi GO II, and Velocyt systems. Revenue generated through direct sales with customized quotes based on workflow requirements.

precisioncellsystems.com
2Consumables and Reagents
TypeSubscription Recurring
Description

Recurring revenue from specialized consumables including cell analysis cassettes (Moxi Cell Analysis Cassettes, Moxi Cell Counting Cassettes), nuclei isolation cartridges (V2 150/40 dual filter cartridges, NIC+ cartridges, FFPE Flowthrough cartridges), and tissue-specific reagents. Also includes validation check beads and viability reagents.

precisioncellsystems.com
3Kits and Bundles
TypeHardware Sales
Description

Pre-configured kit bundles including Nuclei Isolation Bundles (8, 24, 96 samples), NIC+ Isolation Bundles, FFPE Nuclei Isolation Bundles, Heart Cell Isolation Bundles, and Moxi Validation/Viability Kits for specific applications.

precisioncellsystems.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Technology or R&D, Personnel, Marketing or Sales, Supply Chain, Infrastructure
Pricing details4 tiers
1Singulator 200 - Automated tissue dissociation for labs with automated FFPE needs
ModelOne time/ perpetual licenseBilling cadenceMulti-year contract
Notes

Quote-based pricing based on workflow requirements. Designed for core labs and clinical labs processing >16 samples/day with dual sample processing capability.

precisioncellsystems.com
2Singulator 200+ - Enhanced platform with dual sample processing
ModelOne time/ perpetual licenseBilling cadenceMulti-year contract
Notes

16 samples/hour fresh/frozen nuclei isolations, 2 FFPE nuclei isolations/hour. Quote-based pricing for labs with higher throughput requirements.

precisioncellsystems.com
3Moxi Product Line - Coulter principle cell analyzers
ModelOne time/ perpetual licenseBilling cadenceMulti-year contract
Notes

Moxi Z (essential counting), Moxi V (enhanced viability), Moxi GO II (premium performance with 2-color flow cytometry). Pricing requires login or quote request.

precisioncellsystems.com
4Consumables and Reagent Bundles
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Nuclei Isolation Bundles (8 samples starting, 24 samples, 96 cartridges), NIC+ Isolation Bundles, FFPE Nuclei Isolation Bundles, Moxi Validation/Viability Kits. Available through online store with account pricing.

precisioncellsystems.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Precision Cell Systems manufactures and sells automated cell analysis instruments and proprietary consumables for single-cell genomics workflows. The Singulator platform automates tissue dissociation and nuclei isolation from fresh, frozen, and FFPE samples, while the Moxi platform combines Coulter-principle cell counting with fluorescent flow cytometry for cell sizing, concentration, and viability measurements. Recurring revenue is generated from cassettes, cartridges, reagents, and pre-configured isolation bundles sold through an online store.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 81% reduction in hands-on time for tissue dissociation workflows
+4 more records
Product overview1 text field

Precision Cell Systems offers a unified platform of automated cell analysis instruments and consumables designed for single-cell genomics workflows. The core portfolio comprises the Singulator family (automated tissue dissociation for fresh, frozen, and FFPE nuclei isolation) and the Moxi family (Coulter-based cell counters with integrated flow cytometry). A newly announced product, Velocyt, targets intact spheroid and organoid analysis. The company, formed from the merger of Orflo and S2 Genomics with subsequent acquisition of BennuBio, serves 700+ customers in research, biopharma, and clinical labs. Products integrate with major single-cell sequencing platforms including 10x Genomics, Parse Biosciences, and others for downstream analysis.

Product and service9 records
1Singulator 100
CategoryAutomated tissue dissociation instrument
Description

Entry-level automated tissue dissociation system for nuclei isolation from fresh, frozen, and FFPE tissue samples, providing standardized single-cell sample preparation for research labs.

2Singulator 200
CategoryAutomated tissue dissociation instrument
Description

Automated dissociation system that processes 16 samples per hour for fresh/frozen nuclei isolations, reducing 15+ manual steps to just 2 hands-on steps and delivering consistent, high-quality nuclei preps for snRNA-seq workflows. Designed for core labs and clinical labs processing >16 samples/day.

3Singulator 200+
CategoryAutomated tissue dissociation instrument
Description

Advanced dual-sample processing model with automated 60-minute walk-away FFPE workflow. Supports FFPE nuclei isolations at 2 samples per run with a specialized GREEN cartridge for enzyme-free deparaffinization, automating deparaffinization, rehydration, and nuclei isolation for labs with higher throughput needs.

4Moxi Z
CategoryAutomated cell analyzer
Description

Palm-sized, cost-effective Coulter-principle cell counting and sizing system designed for routine counting and budget-conscious labs without fluorescence capability. Provides NIST-traceable size measurement (3-34µm) and concentration with <2% CV precision.

5Moxi V
CategoryAutomated cell analyzer
Description

Enhanced viability analysis system combining Coulter counting with 1-channel fluorescent viability for accurate nuclei counting and cell viability assessment, providing true size (3-34µm) and concentration measurements with debris-immune detection.

6Moxi GO II
CategoryAutomated cell analyzer
Description

Premium benchtop flow cytometer combining Coulter-principle counting with 2-channel fluorescence. Supports phenotyping, reporter gene checking, CAR T analysis, apoptosis detection, and comprehensive cell health monitoring for cell therapy QC and FDA-compliant workflows.

7Singulator Consumables and Reagents
CategoryConsumables and reagents
Description

Proprietary cartridges, reagents, and isolation bundles for Singulator instruments including dual filter V2 150/40 cartridges, NIC+ cartridges, FFPE Flowthrough cartridges, nuclei isolation reagents, RNase inhibitors, and tissue-specific reagents. Sold as standalone products through the online store.

8Moxi Consumables and Reagents
CategoryConsumables and reagents
Description

Cell analysis cassettes (S+, M+), cell counting cassettes, validation check beads, and viability reagents (Acridine Orange/Propidium Iodide) for use with Moxi instruments. Sold as standalone products through the online store.

9Nuclei Isolation Bundles and Kits
CategoryPre-configured kits and bundles
Description

Pre-configured kit bundles including Nuclei Isolation Bundles (8, 24, and 96 samples), NIC+ Isolation Bundles, FFPE Nuclei Isolation Bundles, Heart Cell Isolation Bundles, and Moxi Validation/Viability Kits designed for specific applications and offered as standalone products through the online store.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-10-22
Description

Precision Cell Systems and Planet Innovation (PI), a MedTech contract development and manufacturing organization (CDMO), formed a unique partnership that consolidates cell analysis technologies and supports them with common commercial and operational infrastructure. This partnership aims to grow the cell analysis ecosystem through shared manufacturing capabilities, quality systems, and customer support infrastructure.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Dominant single-cell genomics platform provider whose Chromium, Xenium, Visium, and MERFISH workflows are validated as downstream applications for PCS's Singulator and Moxi products. 10x also competes indirectly via integrated sample prep and QC capabilities within its own ecosystem.

TypeDirect peer
Description

Direct competitor in automated tissue dissociation (gentleMACS Octo Dissociator) and cell analysis (MACSQuant flow cytometers). Miltenyi serves the same biopharma and academic cell therapy QC segments as PCS's Singulator and Moxi product lines.

TypeBroad incumbent
Description

Major flow cytometry incumbent (FACSChorus, FACSDiscover, BD CellView Image) competing with PCS's Moxi GO II and Velocyt platforms. BD's massive installed base, service network, and reagent portfolio represent both competition and a potential strategic acquirer profile.

TypeBroad incumbent
Description

Cell counting and flow cytometry incumbent (Vi-Cell, CytoFLEX, MoFlo Astrios) competing directly with Moxi for routine cell analysis and viability workflows. Part of Danaher's broader life sciences instrumentation portfolio.

TypeBroad incumbent
Description

Cell counter (TC20, TC10) and flow cytometry (ZE5, S3e) competitor serving similar academic and biopharma segments as PCS. Bio-Rad's ddPCR and Droplet Digital systems overlap with downstream single-cell applications.

TypeDirect peer
Description

Flow cytometry specialist (Aurora, Northern Lights) competing with Moxi GO II in cell phenotyping and multi-parameter analysis. Cytek's spectral flow cytometry is a competing approach to Moxi's Coulter-plus-fluorescence design.

TypeDirect peer
Description

Single-cell sequencing platform (Evercode WT, Evercode TCR) validated as a downstream application of Singulator sample preparation. Parse competes with 10x Chromium and serves overlapping academic and biopharma customers.

TypeDirect peer
Description

Single-cell multi-omics platform (Tapestri) for DNA and protein analysis at single-cell resolution, validated as compatible with Singulator sample prep. Competes in single-cell oncology and cell therapy QC workflows; also a prior employer of PCS CEO Anup Parikh.

TypeDirect peer
Description

Microfluidic cell sorting and analysis (WOLF Cell Sorter, N1 Single Cell Dispenser) targeting similar cell therapy manufacturing QC and single-cell genomics workflows as Moxi GO II.

TypeDirect peer
Description

On-chip flow cytometry and single-cell analysis (On-chip Sort) competing in cell analysis and sorting for life science research. Comparable benchtop form factor and target market to Moxi.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration8 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Precision Cell Systems

Cell Analysis Instrumentsprecisioncellsystems.com

Precision Cell Systems is a cell-analysis instrumentation company formed in 2025 from the merger of S2 Genomics and ORFLO and the acquisition of BennuBio, selling automated tissue dissociation (Singulator), Coulter principle cell counters (Moxi), and forthcoming 3D spheroid/organoid flow cytometry (Velocyt) to academic, biopharma, and clinical-lab customers.

What Precision Cell Systems does

Precision Cell Systems (PCS), headquartered in Livermore, California, is a privately held life-sciences instrumentation company formed in September 2025 through the simultaneous acquisition of S2 Genomics (developer of the Singulator automated tissue dissociation platform) and ORFLO (developer of the Moxi Coulter principle-based cell analyzers), followed in October 2025 by the acquisition of BennuBio (developer of the Velocyt intact spheroid/organoid flow cytometer). The company addresses sample-preparation and analysis bottlenecks for single-cell genomics, cell therapy manufacturing QC, and 3D cell culture workflows, serving an installed base of more than 700 academic, biopharma, core-lab, and clinical-lab customers.

The product portfolio centers on three hardware platforms: the Singulator family (Singulator 100/200/200+) which fully automates fresh, frozen, and FFPE tissue dissociation down to inputs as small as 2 mg or 50 µm curls using a patented minimal-loss cartridge system; the Moxi family (Z, V, GO II, Flow) which uses the Coulter impedance principle to deliver NIST-traceable cell sizing and concentration with <2% CV precision, optionally combined with 1- or 2-channel fluorescence for viability, phenotyping, and reporter assays; and the Velocyt platform (in development) for high-throughput intact spheroid and organoid analysis. Recurring revenue is generated through proprietary consumables—cartridges, cassettes, isolation bundles, and reagents—while instrument revenue is captured via multi-year, quote-based enterprise sales supported by a 3-step workflow assessment process that includes 21 CFR Part 11 compliance capture.

PCS employs a sales-led, enterprise field-sales motion complemented by a direct e-commerce storefront, a large content/resource library (171 Moxi resources, 109 Singulator resources), and a webinar series. Customers include Harvard Medical School, UCSF, Yale, UPenn School of Medicine, Janssen, and consortia such as Tabula Muris, with product performance validated by 156+ peer-reviewed publications across Nature, PNAS, Cell Stem Cell, and Science Immunology. Outputs are validated for downstream compatibility with 10x Genomics (Chromium, Xenium, Visium, MERFISH), Parse Evercode, Mission Bio Tapestri, BioSkryb ResolveDNA, and BioSpyder TempO-LINC, embedding PCS upstream in the dominant single-cell genomics workflow. Leadership comprises CEO Anup Parikh, PhD (ex-BroadOak Capital Partners, 10x Genomics, Mission Bio, Ion Torrent); COO Bruce Leisz (ex-S2 Genomics, Pacific Biosciences, Affymetrix); and CCO Terry Salyer, with operational scaling supported by a partnership with MedTech CDMO Planet Innovation.

Precision Cell Systems firmographics

Firmographics
Name
Precision Cell Systems
Legal name
Precision Cell Systems, Inc.
Website
https://precisioncellsystems.com
Company type
Private
Founded year
2025
Operating status
Operating
Headcount range
11–50 employees
Short description
Precision Cell Systems is a cell-analysis instrumentation company formed in 2025 from the merger of S2 Genomics and ORFLO and the acquisition of BennuBio, selling automated tissue dissociation (Singulator), Coulter principle cell counters (Moxi), and forthcoming 3D spheroid/organoid flow cytometry (Velocyt) to academic, biopharma, and clinical-lab customers.
Ownership category
akta.pro rank

Precision Cell Systems industry classification

Industry
Product category
Cell Analysis Instruments
NAICS
Analytical Laboratory Instrument Manufacturing (334516), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
SIC
Laboratory Analytical Instruments (3826)
akta.pro industry
PRIMARYHLAGAIAE
Microscopy, Imaging & Flow Cytometry Instruments
SECONDARYHLAAABAK
Cell Therapy Quality, Analytics & Release Testing (potency, sterility, comparability)
Healthcare & Life Sciences/Biotechnology & Biologics/Cell Therapy (autologous/allogeneic)
SECONDARYHLAAAIAJ
In Vitro Model Systems & Organoid Platforms (iPSC/organoids, microphysiological systems)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
SECONDARYHLAAABAH
Cell Processing & Ancillary Materials (media, cytokines, beads, vectors, disposables)
Healthcare & Life Sciences/Biotechnology & Biologics/Cell Therapy (autologous/allogeneic)

Keywords

  • Automated tissue dissociation
  • Cell analysis instruments
  • Single-cell genomics
  • Flow cytometry platforms
  • Nuclei isolation systems

Where Precision Cell Systems is headquartered

Location

Headquarters

HQ city
Livermore
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Precision Cell Systems business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Technology or R&D, Personnel, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

  1. Instrument Hardware Sales: Sale of automated cell analysis instruments including Singulator 200, Singulator 200+, Moxi Z, Moxi V, Moxi GO II, and Velocyt systems. Revenue generated through direct sales with customized quotes based on workflow requirements.
  2. Consumables and Reagents: Recurring revenue from specialized consumables including cell analysis cassettes (Moxi Cell Analysis Cassettes, Moxi Cell Counting Cassettes), nuclei isolation cartridges (V2 150/40 dual filter cartridges, NIC+ cartridges, FFPE Flowthrough cartridges), and tissue-specific reagents. Also includes validation check beads and viability reagents.
  3. Kits and Bundles: Pre-configured kit bundles including Nuclei Isolation Bundles (8, 24, 96 samples), NIC+ Isolation Bundles, FFPE Nuclei Isolation Bundles, Heart Cell Isolation Bundles, and Moxi Validation/Viability Kits for specific applications.

Pricing tiers

ModelBillingPrice
One time/ perpetual licenseMulti-year contractSingulator 200 - Automated tissue dissociation for labs with automated FFPE needs
One time/ perpetual licenseMulti-year contractSingulator 200+ - Enhanced platform with dual sample processing
One time/ perpetual licenseMulti-year contractMoxi Product Line - Coulter principle cell analyzers
Unit PricingPay-as-you-goConsumables and Reagent Bundles

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Precision Cell Systems product offering

Product offering

Core offering

Precision Cell Systems manufactures and sells automated cell analysis instruments and proprietary consumables for single-cell genomics workflows. The Singulator platform automates tissue dissociation and nuclei isolation from fresh, frozen, and FFPE samples, while the Moxi platform combines Coulter-principle cell counting with fluorescent flow cytometry for cell sizing, concentration, and viability measurements. Recurring revenue is generated from cassettes, cartridges, reagents, and pre-configured isolation bundles sold through an online store.

Product overview

Precision Cell Systems offers a unified platform of automated cell analysis instruments and consumables designed for single-cell genomics workflows. The core portfolio comprises the Singulator family (automated tissue dissociation for fresh, frozen, and FFPE nuclei isolation) and the Moxi family (Coulter-based cell counters with integrated flow cytometry). A newly announced product, Velocyt, targets intact spheroid and organoid analysis. The company, formed from the merger of Orflo and S2 Genomics with subsequent acquisition of BennuBio, serves 700+ customers in research, biopharma, and clinical labs. Products integrate with major single-cell sequencing platforms including 10x Genomics, Parse Biosciences, and others for downstream analysis.

Differentiator

Problem solved

Functional benefit

Products and services

  • Singulator 100 Entry-level automated tissue dissociation system for nuclei isolation from fresh, frozen, and FFPE tissue samples, providing standardized single-cell sample preparation for research labs.
  • Singulator 200 Automated dissociation system that processes 16 samples per hour for fresh/frozen nuclei isolations, reducing 15+ manual steps to just 2 hands-on steps and delivering consistent, high-quality nuclei preps for snRNA-seq workflows. Designed for core labs and clinical labs processing >16 samples/day.
  • Singulator 200+ Advanced dual-sample processing model with automated 60-minute walk-away FFPE workflow. Supports FFPE nuclei isolations at 2 samples per run with a specialized GREEN cartridge for enzyme-free deparaffinization, automating deparaffinization, rehydration, and nuclei isolation for labs with higher throughput needs.
  • Moxi Z Palm-sized, cost-effective Coulter-principle cell counting and sizing system designed for routine counting and budget-conscious labs without fluorescence capability. Provides NIST-traceable size measurement (3-34µm) and concentration with <2% CV precision.
  • Moxi V Enhanced viability analysis system combining Coulter counting with 1-channel fluorescent viability for accurate nuclei counting and cell viability assessment, providing true size (3-34µm) and concentration measurements with debris-immune detection.
  • Moxi GO II Premium benchtop flow cytometer combining Coulter-principle counting with 2-channel fluorescence. Supports phenotyping, reporter gene checking, CAR T analysis, apoptosis detection, and comprehensive cell health monitoring for cell therapy QC and FDA-compliant workflows.
  • Singulator Consumables and Reagents Proprietary cartridges, reagents, and isolation bundles for Singulator instruments including dual filter V2 150/40 cartridges, NIC+ cartridges, FFPE Flowthrough cartridges, nuclei isolation reagents, RNase inhibitors, and tissue-specific reagents. Sold as standalone products through the online store.
  • Moxi Consumables and Reagents Cell analysis cassettes (S+, M+), cell counting cassettes, validation check beads, and viability reagents (Acridine Orange/Propidium Iodide) for use with Moxi instruments. Sold as standalone products through the online store.
  • Nuclei Isolation Bundles and Kits Pre-configured kit bundles including Nuclei Isolation Bundles (8, 24, and 96 samples), NIC+ Isolation Bundles, FFPE Nuclei Isolation Bundles, Heart Cell Isolation Bundles, and Moxi Validation/Viability Kits designed for specific applications and offered as standalone products through the online store.

Quantifiable outcome

  • 81% reduction in hands-on time for tissue dissociation workflows
  • +4 more outcomes

Companies that use Precision Cell Systems

Customer profile

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Precision Cell Systems technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration8 records

Feature3 records

Precision Cell Systems partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Planet InnovationcoreStrategic or Co-development Partner · 22 October 2025Precision Cell Systems and Planet Innovation (PI), a MedTech contract development and manufacturing organization (CDMO), formed a unique partnership that consolidates cell analysis technologies and supports them with common commercial and operational infrastructure. This partnership aims to grow the cell analysis ecosystem through shared manufacturing capabilities, quality systems, and customer support infrastructure.

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

Precision Cell Systems competitors and assessment

Company assessment

Broad incumbents

  • 10x Genomics: Dominant single-cell genomics platform provider whose Chromium, Xenium, Visium, and MERFISH workflows are validated as downstream applications for PCS's Singulator and Moxi products. 10x also competes indirectly via integrated sample prep and QC capabilities within its own ecosystem.
  • BD Biosciences: Major flow cytometry incumbent (FACSChorus, FACSDiscover, BD CellView Image) competing with PCS's Moxi GO II and Velocyt platforms. BD's massive installed base, service network, and reagent portfolio represent both competition and a potential strategic acquirer profile.
  • Beckman Coulter Life Sciences (Danaher): Cell counting and flow cytometry incumbent (Vi-Cell, CytoFLEX, MoFlo Astrios) competing directly with Moxi for routine cell analysis and viability workflows. Part of Danaher's broader life sciences instrumentation portfolio.
  • Bio-Rad Laboratories: Cell counter (TC20, TC10) and flow cytometry (ZE5, S3e) competitor serving similar academic and biopharma segments as PCS. Bio-Rad's ddPCR and Droplet Digital systems overlap with downstream single-cell applications.

Direct peers

  • Miltenyi Biotec: Direct competitor in automated tissue dissociation (gentleMACS Octo Dissociator) and cell analysis (MACSQuant flow cytometers). Miltenyi serves the same biopharma and academic cell therapy QC segments as PCS's Singulator and Moxi product lines.
  • Cytek Biosciences: Flow cytometry specialist (Aurora, Northern Lights) competing with Moxi GO II in cell phenotyping and multi-parameter analysis. Cytek's spectral flow cytometry is a competing approach to Moxi's Coulter-plus-fluorescence design.
  • Parse Biosciences: Single-cell sequencing platform (Evercode WT, Evercode TCR) validated as a downstream application of Singulator sample preparation. Parse competes with 10x Chromium and serves overlapping academic and biopharma customers.
  • Mission Bio: Single-cell multi-omics platform (Tapestri) for DNA and protein analysis at single-cell resolution, validated as compatible with Singulator sample prep. Competes in single-cell oncology and cell therapy QC workflows; also a prior employer of PCS CEO Anup Parikh.
  • NanoCellect Biomedical: Microfluidic cell sorting and analysis (WOLF Cell Sorter, N1 Single Cell Dispenser) targeting similar cell therapy manufacturing QC and single-cell genomics workflows as Moxi GO II.
  • On-chip Biotechnologies: On-chip flow cytometry and single-cell analysis (On-chip Sort) competing in cell analysis and sorting for life science research. Comparable benchtop form factor and target market to Moxi.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Precision Cell Systems social profiles

Digital presence

Precision Cell Systems compliance and trust

Trust signal

Compliance3 records

Precision Cell Systems financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Precision Cell Systems leadership team

Management profile

Number of profiles

Profiles3 records

Precision Cell Systems subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

Precision Cell Systems funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Precision Cell Systems M&A and investment

M&A and investment

M&A3 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Precision Cell Systems

What does Precision Cell Systems do?

Precision Cell Systems manufactures and sells automated cell analysis instruments and proprietary consumables for single-cell genomics workflows. The Singulator platform automates tissue dissociation and nuclei isolation from fresh, frozen, and FFPE samples, while the Moxi platform combines Coulter-principle cell counting with fluorescent flow cytometry for cell sizing, concentration, and viability measurements. Recurring revenue is generated from cassettes, cartridges, reagents, and pre-configured isolation bundles sold through an online store.

Is Precision Cell Systems a public or private company?

Precision Cell Systems is a private company. It is classified as unknown and is currently operating.

When was Precision Cell Systems founded?

Precision Cell Systems was founded in 2025. It employs 11 to 50 people.

Where is Precision Cell Systems based?

Precision Cell Systems is headquartered in Livermore, United States, in the North America region.

How does Precision Cell Systems make money?

Three revenue lines are on record. Instrument Hardware Sales are the primary driver. The others are consumables and Reagents and kits and Bundles.

Who are Precision Cell Systems's main competitors?

Broad incumbents on record are 10x Genomics, BD Biosciences, Beckman Coulter Life Sciences (Danaher) and Bio-Rad Laboratories. Direct peers are Miltenyi Biotec, Cytek Biosciences, Parse Biosciences, Mission Bio, NanoCellect Biomedical and On-chip Biotechnologies.

Does Precision Cell Systems have an API?

No public API is recorded for Precision Cell Systems.

What industry is Precision Cell Systems in?

Precision Cell Systems's product category is Cell Analysis Instruments. Its primary akta.pro industry code is HLAGAIAE, Microscopy, Imaging & Flow Cytometry Instruments, with a secondary code of HLAAABAK, Cell Therapy Quality, Analytics & Release Testing (potency, sterility, comparability). Its NAICS code is 334516 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Third NewsPrecision Cell Systems Makes a Bold Move with BennuBio Acquisition to Tackle 3D Cell CulturePrecision Cell Systems has acquired BennuBio, a life science firm based in New Mexico, integrating the company's Velocyt imaging flow cytometer technology into its portfolio for high-throughput analysis of 3D cell culture models including spheroids and organoids. The deal marks PCS's third acquisition in 2025 alongside S2 Genomics and ORFLO, as the company executes a consolidation strategy in the rapidly expanding 3D cell culture market projected to grow from over $1.7 billion to more than $3.2 billion by 2030. The acquisition also brings BennuBio's primary investor Tramway Ventures into PCS's shareholder base, providing additional financial backing for scaling the technology.PR NewswirePrecision Cell Systems Acquires BennuBio to Enter the 3D Cell Culture MarketPrecision Cell Systems (PCS) announced its acquisition of BennuBio, a New Mexico-based company specializing in high-throughput analysis of 3D multicellular models, to enter the 3D cell culture market. This strategic move expands PCS's capabilities in single-cell analysis and biotechnology applications, aligning with its growth strategy. The 3D cell culture market is expected to grow significantly, surpassing $3.2 billion by 2030.PR NewswirePrecision Cell Systems Completes Two Acquisitions to Consolidate Best-in-Class Technologies Serving 700+ Customers for Cell AnalysisPrecision Cell Systems launched after acquiring S2 Genomics and ORFLO, consolidating cell analysis technologies. The company reports over 1,000 installed instruments, 700+ active customers, and a 35% operating expense reduction. It plans further acquisitions to build a comprehensive workflow platform.